Baseline characteristics | Valuea |
---|---|
Median (IQR) age, years | 35.8 (29.9–42.5) |
Male | 1883 (72.6) |
HIV exposure | |
Heterosexual | 1456 (56.2) |
Homosexual | 778 (30.0) |
Intravenous drug use | 93 (3.6) |
Other | 265 (10.2) |
Median (IQR) body mass index, kg/m2 | 21.1 (19.0–23.4) |
Missing | 683 (26.4) |
Anemia | |
No, n (% tested) | 1208 (50.7) |
Yes, n (% tested) | 1176 (49.3) |
Unknown | 208 (8.0) |
Hepatitis B surface antigen | |
Negative, n (% tested) | 1925 (89.2) |
Positive, n (% tested) | 232 (10.8) |
Unknown | 435 (16.8) |
Hepatitis C antibody | |
Negative, n (% tested) | 1844 (91.7) |
Positive, n (% tested) | 168 (8.3) |
Unknown | 580 (22.4) |
Syphilis serology | |
Negative, n (% tested) | 825 (80.4) |
Positive, n (% tested) | 201 (19.6) |
Unknown | 1566 (60.4) |
Median (IQR) duration of HIV diagnosis, months | 4.3 (1.4–29.2) |
Missing | 29 (1.1) |
HIV subtype | |
CRF01_AE, n (% tested) | 796 (75.1) |
B, n (% tested) | 173 (16.3) |
Other, n (% tested) | 91 (8.6) |
Unknown | 1532 (59.1) |
Median (IQR) HIV RNA, copies/mL | 100,000 (34,045–301,075) |
Median (IQR) CD4 count, cells/mm3 | 147 (50–248) |
Missing | 106 (4.1) |
Median (IQR) CD8 count, cells/mm3 | 753 (485–1103) |
Missing | 1268 (48.9) |
Median (IQR) CD4:CD8 ratio | 0.19 (0.09–0.32) |
Missing | 1268 (48.9) |
Median (IQR) total lymphocyte count, cells/mm3 | 1472 (1000–2005) |
Missing | 286 (11.0) |
Prior AIDS illness | |
No | 1698 (65.5) |
Yes | 894 (34.5) |